# PTH - Preemptive Treatment for Herpesviridae

> **NCT02152358** · PHASE4 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 317 (actual)

## Conditions studied

- Viral Pneumonia

## Interventions

- **DRUG:** Aciclovir
- **DRUG:** Ganciclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02152358
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-05
- **Primary completion:** 2018-04-21
- **Final completion:** 2023-04-05
- **Target enrollment:** 317 (ACTUAL)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02152358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02152358, "PTH - Preemptive Treatment for Herpesviridae". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02152358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*